scholarly journals Tobacco consumption has interaction effect with protein coding genes to increase esophageal squamous cell Carcinoma risk: A case-control study in Chinese high-incidence region

Author(s):  
Renjia Zhao ◽  
Huangbo Yuan ◽  
Zhenqiu Liu ◽  
Xiaoxiao Li ◽  
Huiyao Chen ◽  
...  

Abstract Background: Esophageal squamous cell carcinoma (ESCC) has reported that smoking was a major risk factor. Genetic predisposition can partially explain the pathogenesis of esophageal cancer in alcohol drinkers. It would also be interesting to investigate the genetic basis underlying the significant disparities in ESCC risk in populations exposed to the same level of smoking. Methods: We recruited 1030 ESCC patients and 1783 healthy individuals in Taixing, China, and selected 101 ESCC-related SNPs for analysis. Logistic regression model was employed with an interaction term for smoking and individual SNPs. The level of smoking was categorized based on pack-years as never smokers, moderate smokers (≤30), and heavy smokers (>30). The relative excess risk of interaction (RERI) and the synergy index (S) were used to evaluate interaction on an additive scale. Genetic risk score was established to quantify gene risk. Results: The SNP HECTD4 rs11066280, CASP8 rs3769823 and ADH1B rs1042026 had an interaction effect with smoking on ESCC risk. Specifically, for rs11066280 T/A, the adjusted OR for moderate and heavy smokers was 1.43 (95% CI = 1.01-2.02) and 1.80 (95% CI = 1.28–2.53), ADH1B rs1042026 showed strong effect in both smoker and alcohol drinkers. GRS indicated that these three SNPs had unsignificant effect in non-smokers and a 2.92-fold risk (95%CI = 1.69-5.11) in smokers.Discussion and Conclusion: In this study, we provide new insights for disease prevention and control of ESCC based on smoking behavior and genetic predisposition.

Tumor Biology ◽  
2017 ◽  
Vol 39 (2) ◽  
pp. 101042831769223 ◽  
Author(s):  
Xiaoying Chen ◽  
Haochang Hu ◽  
Jing Liu ◽  
Yong Yang ◽  
Guili Liu ◽  
...  

Esophageal squamous cell carcinoma is a commonly malignant tumor of digestive tract with poor prognosis. Previous studies suggested that forkhead box F2 ( FOXF2) could be a candidate gene for assessing and predicting the prognosis of human cancers. However, the relationship between FOXF2 promoter methylation and the prognosis of esophageal squamous cell carcinoma remained unclear. Formalin-fixed, paraffin-embedded esophageal squamous cell carcinoma tissues of 135 esophageal squamous cell carcinoma patients were detected for FOXF2 promoter methylation status by methylation-specific polymerase chain reaction approach. DNA methylation results were evaluated with regard to clinicopathological features and overall survival. Our study confirmed that FOXF2 promoter hypermethylation could independently predict a poorer overall survival of esophageal squamous cell carcinoma patients ( p = 0.002), which was consistent with the data mining results of the data from 82 esophageal squamous cell carcinoma patients in The Cancer Genome Atlas datasets ( p = 0.036). In addition, no correlation was found between FOXF2 promoter methylation and other clinic pathological parameters (age, gender, differentiation, lymph node metastasis, stage, cutting edge, vascular invasion, smoking behavior, and drinking history). In conclusion, FOXF2 methylation might be a useful prognostic biomarker for esophageal squamous cell carcinoma patients.


2012 ◽  
Vol 63 (2) ◽  
pp. 195-195
Author(s):  
K. Minashi ◽  
T. Yano ◽  
T. Kojima ◽  
M. Onozawa ◽  
K. Nihei ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document